Skip to main content
. 2016 Mar 11;11(3):e0151632. doi: 10.1371/journal.pone.0151632

Table 1. Clinicopathologic characteristics of the patients by group.

Variable All Patients (N = 44) Metformin (N = 19) Non-Metformin (N = 25) P Value
Gender, N (%) 1.0000
 Female 14 (31.8) 6 (31.6) 8 (32)
 Male 30 (68.2) 13 (68.4) 17 (68)
Age at diagnosis, N (%) 1.0000
 <60 years 7 (15.9) 3 (15.8) 4 (16)
 60+ years 37 (84.1) 16 (84.2) 21 (84)
Race, N (%)
 Non White 3 (6.8) 1(5.3) 2 (8)
 White 41 (93.2) 18 (94.7) 23 (92%)
BMI, N (%) 0.4152
 ≤25 10 (25.6) 5 (33.3) 5 (20.8)
 25–30 16 (41%) 7 (46.7) 9 (37.5)
 >30 13 (33.3%) 3 (20) 10 (41.7)
Margin status, N (%) 1.0000
 Negative 37 (88.1) 15 (88.2) 22 (88%)
 Positive 5 (11.9) 2 (11.8) 3 (12%)
ECOG, N (%) 0.2807
 0 34 (77.3) 13 (68.4) 21 (84)
 1 10 (22.7) 6 (31.6) 4 (16)
Stage, N (%)
 I 8 (18.2) 5 (26.3) 3 (12) 0.2688
 II 36 (81.8) 14 (73.7) 22 (88)
Grade/differentiation, N (%) 0.8450
 Poor 12 (27.3) 5 (26.3) 7 (28)
 Moderate 19 (43.2) 7 (36.8) 12 (48)
 Well 8 (18.2) 4 (21.1) 4 (16)
 Not reported 4 (11.4) 3 (15.8) 2 (8)
CA 19–9, N (%) 0.2370
 0–35 8 (23.5) 1 (7.7) 7 (33.3)
 >35–1000 15 (44.1) 7 (53.8) 8 (38.1)
 >1000 11 (32.4) 5 (38.5) 6 (28.6)
Albumin, N (%) 0.0617
 ≤3.5 6 (15) 0 (0) 6 (25)
 >3.5 34 (85) 16 (100) 18 (75)
Nodes examined, N (%) 0.7631
 <11 17 (38.6) 8 (42.1) 9 (36%)
 >11 27 (61.4%) 11 (57.9) 16 (64%)
Positive nodes, N (%) 0.3653
 0 21 (47.7) 11 (57.9) 10 (40)
 1+ 23 (52.3) 8 (42.1) 15 (60)
Surgery, N (%)
 Whipple 8 (18.2) 3 (15.8) 5 (20)
 Non Whipple 36 (81.8) 16 (84.2) 20 (80)
Diabetes duration, N (%) 0.4676
 0–2 years 13(46.4) 4 (36.4) 9 (52.9)
 >2 years 15 (53.6) 7 (63.6) 8 (47.1)

BMI, body mass index.